Search Results - Portell, C.A.

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    PHASE 1B STUDY OF ViPOR (VENETOCLAX, IBRUTINIB, PREDNISONE, OBINUTUZUMAB, LENALIDOMIDE) IN RELAPSED/REFRACTORY B‐CELL LYMPHOMA: SAFETY, EFFICACY AND MOLECULAR ANALYSIS

    PHASE 1B STUDY OF ViPOR (VENETOCLAX, IBRUTINIB, PREDNISONE, OBINUTUZUMAB, LENALIDOMIDE) IN RELAPSED/REFRACTORY B‐CELL LYMPHOMA: SAFETY, EFFICACY AND MOLECULAR ANALYSIS by Melani, C.J., Lakhotia, R., Pittaluga, S., Miljkovic, M.D., Portell, C.A., Farah, R.J., Juanitez, A.M., Chou, L.L., Steinberg, S.M., Jaffe, E.S., Staudt, L.M., Roschewski, M.J., Wilson, W.H.

    Published in Hematological oncology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: